Chemify, a Glasgow-based deep tech chemical science company, has received a significant grant from the Bill & Melinda Gates Foundation.

This funding will be utilized to advance Chemify's Chemputation technology for discovering new drug leads aimed at treating tuberculosis (TB) and malaria.

By leveraging their proprietary technology, Chemify aims to deliver innovative drug design and discovery outcomes with a global impact.

Founded by CEO Professor Lee Cronin, Chemify was spun out from the University of Glasgow's Digital Chemistry Laboratory to revolutionize chemical science on a worldwide scale.